方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 糖尿病生活质量测量 (Diabetes Quality of Life Measure, DQOL)× | EORTC QLQ-C30：癌症生活质量评估的核心问卷× | |
|---|---|---|
| 领域 | 健康结局 | 健康结局 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1988 | 1993 |
| 提出者≠ | Diabetes Control and Complications Trial Research Group | Nico Aaronson et al. |
| 类型 | Self-report quality of life questionnaire | Self-report quality of life questionnaire |
| 开创性文献≠ | The Diabetes Control and Complications Trial Research Group. (1988). The Diabetes Quality of Life (DQOL) measure. Diabetes Care, 11(10), 725-732. link ↗ | Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗ |
| 别名 | DQOL, Diabetes Quality of Life, Diabetes QOL | QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale |
| 相关≠ | 4 | 5 |
| 摘要≠ | The DQOL is a patient-reported measure of quality of life impact in people with diabetes. Developed by the Diabetes Control and Complications Trial (DCCT) Research Group in 1988, this 46-item questionnaire assesses how diabetes affects daily functioning, emotional well-being, worry about complications, and satisfaction with life and health. It is widely used in diabetes clinical trials and research to capture the burden of diabetes management and impact on psychosocial well-being. | The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care. |
| ScholarGate数据集 ↗ |
|
|